{
    "Trade/Device Name(s)": [
        "SelectaLyte Electrolyte Analyzer",
        "SelectaLyte\u2122 Electrolyte Analyzer"
    ],
    "Submitter Information": "Awareness Technology, Inc.",
    "510(k) Number": "K171476",
    "Predicate Device Reference 510(k) Number(s)": [
        "K961458"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ",
        "JJE"
    ],
    "Summary Letter Date": "December 29, 2017",
    "Summary Letter Received Date": "January 18, 2018",
    "Submission Date": "February 22, 2018",
    "Regulation Number(s)": [
        "21CFR862.1665",
        "21CFR862.1600",
        "21CFR862.1170",
        "21CFR862.2160"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system",
        "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SelectaLyte Electrolyte Analyzer Model 3910"
    ],
    "Method(s)/Technology(ies)": [
        "Ion selective electrode (ISE)"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for SelectaLyte Electrolyte Analyzer using ion selective electrode technology for quantification of sodium, potassium, and chloride in serum and whole blood",
    "Indications for Use Summary": "For in vitro quantitative measurement of ionized sodium, potassium, and chloride in serum and lithium heparin venous whole blood samples by trained laboratory professionals to aid in the diagnosis and treatment of conditions affecting electrolyte balance",
    "fda_folder": "Clinical Chemistry"
}